Compound Detail
CHEMBL350454
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1nc2c(cc3c4c(cccc42)C(=O)N(CCCNCCNCCCN2C(=O)c4cccc5c4c(cc4nc(C)[nH]c45)C2=O)C3=O)[nH]1
Basic Information
| ChEMBL ID | CHEMBL350454 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | KVWSMKXPHZIFKL-UHFFFAOYSA-N |
2
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
642.7
MW (Da)
4.21
ALogP
8
HBA
4
HBD
156.2
PSA (Ų)
0.12
QED
1
Ro5 Violations
11
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 5.06
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HeLa | IC50 | = | 8750.0 | nM | 5.06 | In vitro concentration required to reduce cell number to 50% in human cervical c... | 12477366 |
| HT-29 | IC50 | = | 15000.0 | nM | 4.82 | In vitro concentration required to reduce cell number to 50% in human colon carc... | 12477366 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 12477366 | 10.1021/jm020950q | HT-29 | 1 |
| 12477366 | 10.1021/jm020950q | HeLa | 1 |
| 12477366 | 10.1021/jm020950q | PC-3 | 1 |
Data from ChEMBL 36 via Core Engine